ARCO is pleased to announce the publication of the Chronic Urticaria Patient Charter, an essential document aimed at improving the quality of life for those living with this complex condition.
This initiative, promoted by experts and international associations, including ARCO, which is part of the Global Allergy and Airways Patient Platform, serves as an important reference point for patients and their families.
In 2023, a group of chronic urticaria patients, patient representatives, healthcare providers, and industry partners collaborated to create this vital document. It clearly outlines what patients with chronic urticaria can expect from their care, emphasizing the importance of a personalized and respectful approach to meet their individual needs.
Chronic urticaria can significantly impact the quality of life, making it crucial for patients to understand that they play an active role in their treatment decisions. The Charter is not just a set of principles but a comprehensive guide to enhancing the dialogue between patients and healthcare providers, promoting more effective and compassionate treatment.
The publication of the Charter is also a call to action for healthcare institutions, medical professionals, and the community to work together to improve access to care, information, and support.
You can learn more by visiting the resources page on the Global Allergy and Airways Patient Platform website.
Comments